Delivery Order SPE2DB22D1202-SPE2DB24FUQF5
Award Date
2/9/24
Potential Completion Date
2/12/24
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and a subsidiary of Cencora, Inc. The contract, valued at $18,144.35, is for the delivery of Vraylar 1.5 mg capsules. This is a firm-fixed-price delivery order contract with a completion date of September 1, 2023. The contract was awarded on August 31, 2023, and there was no set-aside designation indicated. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, worth up to $12,400.01, is for the delivery of Vraylar 4.5 mg capsules over a two-year period, with a completion date of October 12, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $5,258.21, is for the delivery of Vraylar 1.5 mg capsules. The contract is a Firm Fixed Price Delivery Order that runs through December 5, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,151.88 firm fixed-price delivery order is for the supply of Vraylar 1.5 mg capsules, a medication used in the treatment of mental health conditions. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Vraylar 1.5 mg capsules. The contract has a ceiling value of $10,036.85 and is a Firm Fixed Price Delivery Order, with a completion date of May 21, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, valued at $4,138.36, is for the delivery of Vraylar 1.5 mg capsules to support the DLA's medical supply needs. The contract has a completion date of December 7, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order worth $14,580.26 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the supply of Vraylar 3 mg capsules, a pharmaceutical product, to support federal healthcare programs. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $14,308.00, is for the delivery of Vraylar 1.5 mg capsules. It was issued as a Firm Fixed Price delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,160.62, is a delivery order for the pharmaceutical product Vraylar 1.5 mg capsule. The contract has an ultimate completion date of September 27, 2023 and is a firm-fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $10,250.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Vraylar 1.5 mg capsule, which has a completion date of February 15, 2024. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...